CN109620925A - 一种治疗小儿疳积病脾虚食积热证的中药组合物 - Google Patents
一种治疗小儿疳积病脾虚食积热证的中药组合物 Download PDFInfo
- Publication number
- CN109620925A CN109620925A CN201910012346.6A CN201910012346A CN109620925A CN 109620925 A CN109620925 A CN 109620925A CN 201910012346 A CN201910012346 A CN 201910012346A CN 109620925 A CN109620925 A CN 109620925A
- Authority
- CN
- China
- Prior art keywords
- stir
- chinese medicine
- baked
- fructus
- dyspepsia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 210000000952 spleen Anatomy 0.000 title claims abstract description 27
- 230000007812 deficiency Effects 0.000 title claims abstract description 18
- 201000006549 dyspepsia Diseases 0.000 title claims description 27
- 208000024891 symptom Diseases 0.000 title claims description 21
- 208000002720 Malnutrition Diseases 0.000 title claims description 17
- 230000001071 malnutrition Effects 0.000 title claims description 17
- 235000000824 malnutrition Nutrition 0.000 title claims description 17
- 208000015380 nutritional deficiency disease Diseases 0.000 title claims description 17
- 239000000203 mixture Substances 0.000 title abstract description 7
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 22
- 241000287828 Gallus gallus Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 241000209094 Oryza Species 0.000 claims description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims description 23
- 235000009566 rice Nutrition 0.000 claims description 23
- 241000219051 Fagopyrum Species 0.000 claims description 21
- 244000197580 Poria cocos Species 0.000 claims description 20
- 235000008599 Poria cocos Nutrition 0.000 claims description 20
- 210000003038 endothelium Anatomy 0.000 claims description 18
- 239000012530 fluid Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 4
- 241000345998 Calamus manan Species 0.000 claims description 3
- 235000012950 rattan cane Nutrition 0.000 claims description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 208000015817 Infant Nutrition disease Diseases 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract description 8
- 241000132012 Atractylodes Species 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 1
- 241000555712 Forsythia Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 238000009825 accumulation Methods 0.000 abstract 1
- 208000003796 chancre Diseases 0.000 abstract 1
- 239000010015 huanglian Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 208000006379 syphilis Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 230000001079 digestive effect Effects 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 9
- 244000000053 intestinal parasite Species 0.000 description 8
- 241001092040 Crataegus Species 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 229930182478 glucoside Natural products 0.000 description 6
- 150000008131 glucosides Chemical group 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 108010019077 beta-Amylase Proteins 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 206010011469 Crying Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000002969 morbid Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- 229920000945 Amylopectin Polymers 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- -1 aldehyde compound Chemical class 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 244000047734 Paederia foetida Species 0.000 description 2
- 235000019116 Paederia foetida Nutrition 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- KZJWDPNRJALLNS-FBZNIEFRSA-N clionasterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-FBZNIEFRSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ZVXWFPTVHBWJOU-AWQYILTISA-N (1s,4as,5r,7as)-5-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C(C(O)=O)=CO1 ZVXWFPTVHBWJOU-AWQYILTISA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 208000003014 Bites and Stings Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 108010065152 Coagulase Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- BZPMXJKRKXDRID-UOIKKKDVSA-N Scandoside Natural products OC[C@H]1O[C@@H](O[C@H]2CC=C([C@@H]3[C@@H](O)C=C(CO)[C@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O BZPMXJKRKXDRID-UOIKKKDVSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000254223 Syntexis Species 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003457 anti-vomiting effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- IBIPGYWNOBGEMH-DILZHRMZSA-N asperuloside Chemical group O([C@@H]1OC=C2C(=O)O[C@H]3C=C([C@@H]1[C@H]32)COC(=O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBIPGYWNOBGEMH-DILZHRMZSA-N 0.000 description 1
- COUXBBBIXWWAEP-AGUBZPQCSA-N asperuloside Chemical group CC(=O)OCC1=C[C@@H]2OC(=O)C3=CO[C@@H](OC[C@H]4O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]4O)[C@H]1[C@H]23 COUXBBBIXWWAEP-AGUBZPQCSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Chemical group CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002079 cooperative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000000095 emetic effect Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Chemical group CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗小儿疳积病脾虚食积热证的中药组合物及其制备方法。该组合物各成分的重量份数为:金荞麦10‑15、茯苓10‑15、麸炒白术15‑20、鸡矢藤30‑50、鸡内金10‑15、生麦芽10‑15、生谷芽10‑15、炒山楂10‑15、连翘6‑10、陈皮6‑10、胡黄连5‑10,经清理、煎煮、冷却、灌装而成。本发明针对小儿疳积病疗效确切,副作用小,适合临床推广应用。
Description
技术领域
本发明涉及一种治疗小儿疳积病脾虚食积热证的中药组合物及其制备方法。
背景技术
疳积是由于喂养不当,或其他疾病的影响,致使脾胃功能受损,气液耗伤而逐渐形成的一种慢性病证。临床以形体消瘦,饮食异常,面黄发枯,精神萎靡或烦躁不安为特征。本病发病无明显季节性,5岁以下小儿多见。古代疳证被列为儿科四大要证之一。新中国成立后,随着人们生活的不断改善和医疗保健事业的发展,疳证的发病率明显下降,特别是重症患儿明显减少。为了彻底取代陈旧的生产技术,研制一种治愈小儿疳积病的特效药的技术方法是当今药物研究者的重要课题。本发明的目的在于提供一种治疗小儿疳积病脾虚食积热证的中药及其制备方法,它对治疗小儿疳积病脾虚食积热证具有良好的效果,且复发率低。
发明内容
一种治疗小儿疳积病脾虚食积热证的中药,其特征在于它的配方是:鸡屎藤,鸡内金,生麦芽,生谷芽,茯苓,陈皮,麸炒白术,炒山楂,金荞麦,连翘,胡黄连;配方的重量份数为金荞麦10-15、茯苓10-15、麸炒白术15-20、鸡矢藤30-50、鸡内金10-15、生麦芽10-15、生谷芽10-15、炒山楂10-15、连翘6-10、陈皮6-10、胡黄连5-10。
根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述重量份数为金荞麦10、茯苓10、麸炒白术15、鸡矢藤30、鸡内金10、生麦芽10、生谷芽10、炒山楂10、连翘6、陈皮6、胡黄连5。
根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述重量份数为金荞麦15、茯苓15、麸炒白术20、鸡矢藤50、鸡内金15、生麦芽15、生谷芽15、炒山楂15、连翘10、陈皮10、胡黄连10。
根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述配方的重量份数为金荞麦13、茯苓13、麸炒白术17、鸡矢藤40、鸡内金13、生麦芽13、生谷芽13、炒山楂13、连翘8、陈皮8、胡黄连7。
一种权利要求1-4任一项所述治疗小儿疳积食积热证的中药的制备方法,其特征在于步骤如下:
(1)清理:分别将配方中的各味中药清理干净;
(2)煎煮:将清理干净的中药按重量份数金荞麦10-15、茯苓10-15、麸炒白术15-20、鸡矢藤30-50、鸡内金10-15、生麦芽10-15、生谷芽10-15、炒山楂10-15、连翘6-10、陈皮6-10、胡黄连5-10。投入到煎煮器皿中进行煎煮,时间为1-2小时,水的重量是中药的8-10倍;
(3)冷却:将煎煮后的药液冷却到15-20℃时,储存备用;
(4)灌装:将药液灌入包装瓶内制成口服液,每100-150毫升为一个包装瓶。
本发明的使用方法:日服药剂三次,每8小时服用一次,每次服用100 -150毫升药剂。
本发明药理分析:
鸡矢藤:消食导滞,除湿消肿,祛风活血,止痛解毒。治风湿疼痛,腹泻痢疾,肮腹疼痛,气虚浮肿,头昏食少,肝脾肿大,瘰疬,肠痈,无名肿毒,跌打损伤。本品含鸡屎藤甙、鸡屎藤次甙、车叶草甙等环臭蚁醛类化合物及γ-谷甾醇。叶含熊果酚甙0.86%及挥发油等。
胡黄连:具有清热,凉血,燥湿。治疳疾,惊痫,泻痢,劳热骨蒸,自汗,盗汗,吐血,衄血,火眼,痔瘘,疮疡。胡黄连水漫剂(1:4)在试管内对蓝色毛癣苗等皮肤真菌有不同程度抑制作用。根的提取物有利胆、抗菌作用,可用于肝炎及尿路感染。
金荞麦:清热解毒;活血消痈;消疳积热,祛风除湿。主治肺痈;肺热咳喘;咽喉肿痛;痢疾;风湿痹证;跌打损伤;痈肿疮毒,蛇虫咬伤。有祛痰、解热、抗炎、抗肿瘤等作用。体外实验虽无明显抗菌作用,但对金黄色葡萄球菌的凝固酶、溶血素及绿脓杆菌内毒素有对抗作用。
茯苓:具有水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠等作用,还具有健脾、免疫调节、对胃肠功能的影响、抗肿瘤等作用。
白术:健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。土白术健脾,和胃,安胎。用于脾虚食少,泄泻便溏,胎动不安。白术水煎液灌胃给药对小鼠小肠推进炭末胶液运动有明显加强作用。阿托品能明显抑制白术兴奋肠管的作用,推测其兴奋肠运动的作用主要是通过兴奋M-胆碱受体而产生的。白术水煎液对胃肠运动有兴奋作用。
生麦芽:具有食积不消,脘腹胀痛,脾虚食少,乳汁郁积,乳房胀痛,妇女断乳,肝郁胁痛,肝胃气痛。本品含α和β淀粉酶。而淀粉是糖淀粉与胶淀粉的混合物。组成糖淀粉的葡萄糖分子以α-1,4甙键相连,且呈直链排列。胶淀粉是由若干个短直链缩合葡萄糖交叉排列。支链淀粉分子中除α-1,4甙键外还有α-1,6甙键。α与β淀粉酶可水解α-1,4甙键,对α-1,6甙键无作用。β淀粉酶能将糖淀粉完全水解成麦芽糖,α淀粉酶则使之分解成短直键缩合葡萄糖(即糊精),后者可再为β淀粉酶水解成麦芽糖。因此淀粉在α和β淀粉酶的作用下可分解成麦芽糖与糊精。麦芽煎剂对胃酸与胃蛋白酶的分泌似有轻度促进作用。
生谷芽:具有健脾开胃,和中消食。治宿食不化,胀满,泄泻,不思饮食。谷芽含有大量蛋白质酶,维生素A,B族维生素,淀粉及蛋白质等多类营养物质。谷芽有利于蛋白质消化,能消食开胃,促进食欲的作用。另外,谷芽还有行气,和中,消胀功效。用于宿食不化,胀满,泄泻,不思饮食。
陈皮:具理气降逆、调中开胃、燥湿化痰之功。主治脾胃气滞湿阻、胸膈满闷、脘腹胀痛、不思饮食、呕吐秽逆、二便不利、肺气阻滞、咳嗽痰多,亦治乳痈初起。本品具有治疗脘腹胀满,食少吐泻,咳嗽痰多。陈皮所含挥发油,对胃肠道有温和的刺激作用,可促进消化液的分泌,排除肠管内积气,显示了芳香健胃和驱风下气的效用。
山楂:可用于治疗肉食积滞,胃脘胀满,泻痢腹痛,瘀血经闭,产后瘀阻,心腹刺痛,胸痹心痛,疝气疼痛,高脂血症。焦山楂消食导滞作用增强。用于肉食积滞,泻痢不爽。山楂含柠檬酸、山楂酸、熊果酸等多种有机酸,口服后能促进胃液的分泌,增加胃液酸度,提高胃蛋白酶活性,促进蛋白质的消化。山楂中所含的脂肪酶能促进脂肪的消化。山楂对胃肠运动功能具有一定调节作用,能增强大鼠松弛状态胃平滑肌的收缩,但对乙酰胆碱及钡离子引起兔、鼠离体胃肠平滑肌收缩具有明显抑制作用。
鸡内金:用于食积不消,呕吐泻痢,小儿疳积,遗尿,遗精,石淋涩痛,胆胀胁痛口服鸡内金后胃液分泌量、酸度及消化力均见增高,其中消化力之增加出现较迟缓,维持也较久。服药后胃运动机能明显增强,表现在胃运动期之延长及蠕动波之增强,由于胃运动之增强,故胃排空率也大大加快。
连翘:具有清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。连翘能抑制洋地黄对鸽静脉注射的催吐作用,减少呕吐次数,但不改变呕吐的潜伏期,其镇吐效果与注射氯丙嚓两小时后的作用相仿。它又能抑制犬皮下注射阿朴吗啡所引起的呕吐,故推测其镇吐作用原理可能是抑制延脑的催吐化学感受区。
总结:方中麸炒白术、茯苓、陈皮健脾养胃,山楂,鸡内金,生麦芽、生谷芽化有形之食积,金荞麦、鸡矢藤消食导滞,山楂促胃酸分泌,金荞麦具有清热通便的作用,胡黄连清疳积热,连翘清内热,且有止呕之功,此仿保和丸用连翘透食积之热法。全方清热化滞,补中有通,共凑健脾消食清疳积热之功。本发明的配方中各味中草药综合发挥清食积蕴热、健脾祛湿、增强胃肠道蠕动的作用,使各味药产生协同功效,在消除疳积的同时,缓解疳积病夜啼的症状以减少疳积病对小儿的伤害和预防并发症的发生,从而达到根治小儿疳积病的目的。
本发明的临床病例:
一般资料:收治患者200例,其中男110例,女90例,年龄为1-5岁。
主要症状:形体消瘦,饮食异常,面黄发枯,精神萎靡,烦躁不安,夜啼等
治疗方法:日服药剂三次,每8小时服用一次,每次服用30-50毫升药剂。
疗效判定标准:治愈:形体消瘦、饮食异常明显改善。有效:面色发枯、精神萎靡缓解或消失,减少或不再夜啼。
疗效:治愈:120例,有效:180例,治愈率达到60%以上,有效率达到90%以上。
本发明的优越性:本发明为一种治疗小儿疳积食积热病的中药,是多味药物合剂,配方疗效确切,副作用小,适合临床推广应用。本发明的制备方法,工艺简单,成本低,易于制取。
(四)具体实施方式:
实施例1:一种治疗小儿疳积食积病脾虚热证的中药,其特征在于它的配方是鸡矢藤,鸡内金,生麦芽,生谷芽,茯苓,陈皮,麸炒白术,炒山楂,金荞麦,连翘,胡黄连,配方的重量比为金荞麦15、茯苓15、麸炒白术20、鸡矢藤50、鸡内金15、生麦芽15、生谷芽15、炒山楂15、连翘10、陈皮10、胡黄连10。
一种治疗小儿疳积食积病脾虚热证的中药的制备方法,其特征在于步骤如下:
(1)清理:分别将配方中的各味中草药物清理干净;
(2)煎煮:将清理干净的中草药物按重量比金荞麦15、茯苓15、麸炒白术20、鸡矢藤50、鸡内金15、生麦芽15、生谷芽15、炒山楂15、连翘10、陈皮10、胡黄连10分别投入到煎煮器皿中进行蒸煮,时间为60分钟,水的重量是中草药物的10倍 ;
(3)冷却储存备用:将煎煮后的各药液冷却到20℃时,储存备用;
(4)混合:将步骤(3)冷却后的储存备用的各药液混合;
(5)灌装:将药液灌入包装瓶内成口服液制品,每150毫升为一个包装瓶。
本实施例的临床应用:
典型病例2、陈xx,女,5岁,住福建省福州市鼓楼区
症状:厌食恶心,面黄肌瘦,夜啼。
诊断:小儿疳积病治疗:自2016年1月开始服用本药物治疗,日服药剂三次,8小时服用 一次,每次服用50毫升药剂,用沉淀过滤后的白开水送服,服药剂后 20分钟补充白开水150毫升,之后休息一小时。
效果:连续服用10天后,上述症状消失,诸证恢复正常,至今情况稳定。
实施例3:一种治疗小儿疳积食积病脾虚热证的中药,其特征在于它的配方是鸡矢藤,鸡内金,生麦芽,生谷芽,茯苓,陈皮,麸炒白术,炒山楂,金荞麦,连翘,胡黄连,配方的重量比为金荞麦13、茯苓13、麸炒白术13、鸡矢藤40、鸡内金13、生麦芽13、生谷芽13、炒山楂13、连翘13、陈皮13、胡黄连13。
一种治疗小儿疳积食积病脾虚热证的中药的制备方法,其特征在于步骤如下:
(1)清理:分别将配方中的各味中草药物清理干净;
(2)煎煮:将清理干净的中草药物按重量金荞麦13、茯苓13、麸炒白术17、鸡矢藤40、鸡内金13、生麦芽13、生谷芽13、炒山楂13、连翘8、陈皮8、胡黄连7。
分别投入到煎煮器皿中进行煎煮,时间为50分钟,水的重量是中草药物的9 倍;
(3)冷却储存备用:将煎煮后的各药液冷却到18℃时,储存备用;
(4)混合:将步骤(3)冷却后的储存备用的各药液混合;
(5)灌装:将药液灌入包装瓶内成口服液制品,每100毫升为一个包装瓶。
上述步骤(2)中所述煎煮器皿采用搪瓷反应器。
上述步骤(3)所述储存采用密封的搪瓷器皿。
上述步骤(4)所述混合采用搪瓷器皿。
本实施例的临床应用:
典型病例3、赵XX,女,5岁,住福建省福州市晋安区,2016年愈。
症状:厌食,面黄肌瘦,皮肤干燥,易口渴,盗汗。
诊断:小儿疳积
治疗:自2016年11月开始服用本药物治疗,日服药剂三次,每8小时服用一次,每次服用50毫升药剂,用沉淀过滤后的白开水送服,服药剂15分钟补充白开水150毫升,之后休息一小时。
效果:连续服用18天后,上述症状消失,至今情况稳定。
Claims (5)
1.一种治疗小儿疳积病脾虚食积热证的中药,其特征在于它的配方是:鸡矢藤,鸡内金,生麦芽,生谷芽,茯苓,陈皮,麸炒白术,炒山楂,金荞麦,连翘,胡黄连;配方的重量份数为金荞麦10-15、茯苓10-15、麸炒白术15-20、鸡矢藤30-50、鸡内金10-15、生麦芽10-15、生谷芽10-15、炒山楂10-15、连翘6-10、陈皮6-10、胡黄连5-10。
2.根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述重量份数为金荞麦10、茯苓10、麸炒白术15、鸡矢藤30、鸡内金10、生麦芽10、生谷芽10、炒山楂10、连翘6、陈皮6、胡黄连5。
3.根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述重量份数为金荞麦15、茯苓15、麸炒白术20、鸡矢藤50、鸡内金15、生麦芽15、生谷芽15、炒山楂15、连翘10、陈皮10、胡黄连10。
4.根据权利要求1所述一种治疗小儿疳积病脾虚食积热证的中药,其特征在于所述配方的重量份数为金荞麦13、茯苓13、麸炒白术17、鸡矢藤40、鸡内金13、生麦芽13、生谷芽13、炒山楂13、连翘8、陈皮8、胡黄连7。
5.一种权利要求1-4任一项所述治疗小儿疳积病脾虚食积热证的中药的制备方法,其特征在于步骤如下;
(1)清理:分别将配方中的各味中药清理干净;
(2)煎煮:将清理干净的中药按重量份数金荞麦10-15、茯苓10-15、麸炒白术15-20、鸡矢藤30-50、鸡内金10-15、生麦芽10-15、生谷芽10-15、炒山楂10-15、连翘6-10、陈皮6-10、胡黄连5-10投入到煎煮器皿中进行煎煮,时间为1-2小时,水的重量是中药的8-10倍;
(3)冷却:将煎煮后的药液冷却到15-20℃时,储存备用;
(4)灌装:将药液灌入包装瓶内制成口服液,每100-150毫升为一个包装瓶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910012346.6A CN109620925A (zh) | 2019-01-07 | 2019-01-07 | 一种治疗小儿疳积病脾虚食积热证的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910012346.6A CN109620925A (zh) | 2019-01-07 | 2019-01-07 | 一种治疗小儿疳积病脾虚食积热证的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109620925A true CN109620925A (zh) | 2019-04-16 |
Family
ID=66058009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910012346.6A Pending CN109620925A (zh) | 2019-01-07 | 2019-01-07 | 一种治疗小儿疳积病脾虚食积热证的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109620925A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116999517A (zh) * | 2023-07-10 | 2023-11-07 | 厦门市中医院 | 一种中药组合物及其用途 |
-
2019
- 2019-01-07 CN CN201910012346.6A patent/CN109620925A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116999517A (zh) * | 2023-07-10 | 2023-11-07 | 厦门市中医院 | 一种中药组合物及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198262B (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
CN1201668C (zh) | 一种保健凉茶及其制作方法 | |
CN101869626B (zh) | 中药复方制剂舒阴液及其制备与应用 | |
CN102205108B (zh) | 一种治疗胃溃疡的中药制剂及其制备方法 | |
CN101502633B (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN101721667A (zh) | 一种治疗消化不良的中药 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN109620925A (zh) | 一种治疗小儿疳积病脾虚食积热证的中药组合物 | |
CN101391024B (zh) | 治疗肺气肿气管炎哮喘咳嗽的中药制品 | |
CN102205098A (zh) | 一种治疗慢性肠炎的中草药组合物 | |
CN100534507C (zh) | 一种内服治疗慢性肠炎的中药组合物 | |
CN105311602B (zh) | 一种防治小儿哮喘的中药组合物 | |
CN104689275A (zh) | 一种治疗肠易激综合征的中草药组合物 | |
CN104436098A (zh) | 治疗多发性肠息肉的中药制剂 | |
CN103690809B (zh) | 一种治疗结核性胸膜炎的中药组合物膏剂及其制备方法 | |
CN102430004B (zh) | 一种治疗腹泻的中药制剂 | |
CN104189831A (zh) | 一种治疗肠易激综合征的中草药组合物 | |
CN105194241A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN103784714A (zh) | 一种治疗心脾积热型小儿厌食的中药 | |
CN103977349A (zh) | 一种治疗肥胖症的中药灌肠剂 | |
CN118787713A (zh) | 一种治疗老年便秘的中药组合物 | |
CN103845569A (zh) | 一种治疗咳嗽痰多的粥及其制备方法 | |
CN103893740A (zh) | 一种治疗慢性结肠炎的中药 | |
CN101912471A (zh) | 一种治疗小儿消化不良的药物及其制备方法 | |
CN101612338A (zh) | 治疗胃溃疡的中药药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190416 |
|
WD01 | Invention patent application deemed withdrawn after publication |